AAM
PRCT icon

Advisors Asset Management’s Procept Biorobotics PRCT Stock Holding History

Advisors Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Sell
15,050
-14,040
-48% -$352K 0.01% 1059
2026
Q1 		$728K Sell
29,090
-478
-2% -$13.5K 0.01% 875
2025
Q4 		$930K Buy
29,568
+1,817
+7% +$60.3K 0.02% 804
2025
Q3 		$990K Buy
27,751
+287
+1% +$13.1K 0.02% 784
2025
Q2 		$1.58M Buy
27,464
+3,455
+14% +$195K 0.03% 640
2025
Q1 		$1.4M Buy
24,009
+2,165
+10% +$148K 0.03% 661
2024
Q4 		$1.76M Buy
21,844
+9,494
+77% +$811K 0.03% 581
2024
Q3 		$989K Buy
12,350
+2,758
+29% +$196K 0.02% 737
2024
Q2 		$586K Buy
+9,592
New +$570K 0.01% 855

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Advisors Asset Management's PRCT Position: Q2 2026 in Review

Advisors Asset Management reduced its Procept Biorobotics (PRCT) stake by 48% in Q2 2026, selling an estimated $352K and leaving 15,050 shares worth $340K. The position accounts for 0.01% of the portfolio, ranked #1059.

Advisors Asset Management first reported a position in PRCT in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.76M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Advisors Asset Management held 15,050 shares of Procept Biorobotics worth $340K as of Q2 2026.
  • Advisors Asset Management sold 14,040 Procept Biorobotics shares in Q2 2026, an estimated $352K.
  • Procept Biorobotics made up 0.01% of Advisors Asset Management's portfolio in Q2 2026, its #1059 holding.
  • Advisors Asset Management first reported a position in Procept Biorobotics in Q2 2024 and has held it in 9 quarters since.
  • Advisors Asset Management's Procept Biorobotics position peaked at $1.76M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.